课题基金 / 基金详情

Role of IRF-4 in adult T cell Leukemia/lymphoma

Role of IRF-4 in adult T cell Leukemia/lymphoma
IRF-4 在成人 T 细胞白血病/淋巴瘤中的作用
批准号:
15390117
负责人:
MATSUYAMA Toshifumi
金额:
$4.67万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MATSUYAMA Toshifumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.Optimal binding motif of IRF-4 is identified, by selection and amplification binding(SAAB) method. IRF-4 prefers to the motif, 5'-GAAA-3' flanked by CpG. Similar motifs are found in the promoter of human TRAIL and DCIR.2.By analyzing IRF-4 deficient dendritic cells, we show that IRF-4 is important for CD11b^<high>CD8α conventional DCs. IRF-4 and IRF-8 were expressed in the majority of CD11b^<high>CD4^+CD8α^-DCs and CD CD11b^<low>CD8α^+ DCs, respectively, in a mutually exclusive manner. These results imply that IRF-4 and IRF-8 selectively play critical roles in the development of the DC subsets that express them.3.We investigated the transcriptional control of IRF-4 in B lymphocytes. The IRF-4 promoter analysis reveals that the region between -51 and -28 was required for the basal promoter activity. UV photocrosslinking assays identified a novel 60 kDa protein with a similar sequence preference.4.To clarify the direct involvement of IRF-4 in ATL proliferation, we have applied IRF-4 specific siRNA, however, at present, every attempt to reduce the expression of IRF-4 was found unsuccessful.5.By applying membrane array, we found EBI-1/CCR7 may be one of the target genes of IRF-4. It is consistent with our previous finding that ATLL cells express EBI-1/CCR7 and IRF-4 concomitantly.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
Paramagnetic NMR study of Cu(2+)-IDA complex localization on a protein surface and its application to elucidate long distance information.
Cu(2 )-IDA 复合物在蛋白质表面定位的顺磁 NMR 研究及其在阐明长距离信息中的应用。
DOI: --
发表时间: 2004
期刊: FEBS Lett.2004 566:157-61.. 第566巻
影响因子: --
作者: [Horinouchi I., Nakazato H., Kawano T., Iyama K., Furuse A., Arizono K., Machida J., Sakamoto T., Endo F., Hattori S., Nomura M]
通讯作者: Nomura M
Disruption of tumor necrosis factor recepter p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts
肿瘤坏死因子受体 p55 的破坏会损害实验诱导的硬皮病皮肤成纤维细胞中的胶原蛋白周转
DOI: --
发表时间: 2003
期刊: Arthritis & Rheumatism 第48巻第4号
影响因子: --
作者: [Mizoshita, T., Inada, K., Tsukamoto, T., Nozaki, K., Job, T., Itoh, M., Yamamura, Y., Ushijima, T., Nakamura, S., Tatematsu.M., Hiroyuki Murota]
通讯作者: Hiroyuki Murota
Critical roles of interferon regulatory factor- 4(IRF-4) in CD11bhighCD8alpha-dendritic cell development.
干扰素调节因子 4 (IRF-4) 在 CD11bhighCD8α 树突状细胞发育中的关键作用。
DOI: --
发表时间: 2004
期刊: Proc Natl Acad Sci USA. 第101巻
影响因子: --
作者: [Nomura M, Suzuki S et al., Nishiya N et al., Yamamoto Y et al., Nomura M et al., Suzuki S]
通讯作者: Suzuki S
Critical roles of interferon regulatery factor-4(IRF-4) in CD11bhighCD8alpha-dendritic cell development.
干扰素调节因子 4 (IRF-4) 在 CD11bhighCD8α 树突状细胞发育中的关键作用。
DOI: --
发表时间: 2004
期刊: Proc Natl Acad Sci USA. 第101巻
影响因子: --
作者: [Okumura K., Nakamura K., Hisatomi Y., Nagano K., Tanaka Y., Terada K., Sugiyama T., Umeyama K., Matsumoto K., Yamamoto T., Endo F., Mabuchi T et al., Suzuki S]
通讯作者: Suzuki S
12
    Establishment of an interferon transfer factor prevention cell strainuseful on virus hunting
    • 批准号:
      22659092
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.97万
    • 财政年份:
      2010
    • 负责人:
      MATSUYAMA Toshifumi
    • 依托单位:
    Analysis of the acute pancreatitis in the mice deficient for the IRF-2 gene
    • 批准号:
      18390124
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.55万
    • 财政年份:
      2006
    • 负责人:
      MATSUYAMA Toshifumi
    • 依托单位:
    Molecular mechanism of acute pancreatitis provoked by double-stranded RNA
    • 批准号:
      13670530
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      MATSUYAMA Toshifumi
    • 依托单位:
    Role of IFN transcription factors, IRF-1, and IRF-2 in acute hepatic injury model
    • 批准号:
      10470060
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.46万
    • 财政年份:
      1998
    • 负责人:
      MATSUYAMA Toshifumi
    • 依托单位:
    国内基金
    海外基金
    雌激素通过转录因子IRF-4促进子宫γδT细胞产生IL-17诱导SLE发生的机制研究
    • 批准号:
      2023JJ40086
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      康双朋
    • 依托单位:
    转录因子IRF-4通过AhR介导巨噬细胞持续M2极化并促进IRI-AKI后肾脏纤维化的机制研究
    • 批准号:
      81970575
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2019
    • 负责人:
      李志莲
    • 依托单位:
    TLR2通路促进CD8+T细胞代谢调节因子IRF-4/BATF的表达从而增强肝脏内抗病毒免疫应答
    BATF和IRF-4交互对话调控妊娠母-胎识别与耐受机制研究
    • 批准号:
      81571513
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2015
    • 负责人:
      杨菁
    • 依托单位: